Research
-
A new contributor to atherosclerosis
Sean Davies and colleagues are exploring lipid aldehydes produced during oxidative stress and their contribution to HDL dysfunction and atherosclerosis. Read MoreJan 27, 2020
-
Insights on diabetic retinopathy
A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report. Read MoreJan 23, 2020
-
HDL-cholesterol and breast cancer risk
Genetic analyses suggest that high circulating HDL-cholesterol levels may increase breast cancer risk — a surprising finding since increased HDL-cholesterol is thought to be healthy. Read MoreJan 23, 2020
-
Five graduate students named Eisenhower Fellows
Five engineering Ph.D. students have received prestigious Dwight David Eisenhower Transportation Fellowships and one of them was named the top Eisenhower Fellow in the U.S. Read MoreJan 21, 2020
-
Engineers advance efforts to speed blood test results
Vanderbilt engineers are working on a process that ultimately may allow patients to get blood test results fast. Read MoreJan 13, 2020
-
Vanderbilt-led team discovers new genetic disease and defines underlying mechanism
An international research team has discovered a new genetic syndrome caused by mutation of a single gene and named it CATIFA, an acronym for its core symptoms. Read MoreJan 13, 2020
-
Zinc uptake by a deadly pathogen
The increasingly antibiotic-resistant bacterium Acinetobacter baumannii requires zinc to cause infection, and Vanderbilt researchers have identified the zinc uptake system it uses. Read MoreJan 13, 2020
-
Kidambi receives NSH Early Career Award to support atomically thin membrane research
Piran Kidambi has received a 2020 National Science Foundation Faculty Early Career Development grant. Read MoreJan 10, 2020
-
Bone matrix changes during aging
Changes to the bone matrix that occur during aging may point to novel targets for treating osteoporosis. Read MoreJan 10, 2020
-
Structural views of a C. diff toxin
D. Borden Lacy and colleagues used cryo-electron microscopy to define the structure of a C. diff toxin, providing a framework for the design of novel therapeutics. Read MoreJan 10, 2020
-
Kavalali receives Humboldt Research Award
Ege T. Kavalali, PhD, professor and acting chair of the Department of Pharmacology in the Vanderbilt University School of Medicine, has been elected a recipient of a prestigious Humboldt Research Award by the Alexander von Humboldt Foundation of Germany. Read MoreDec 31, 2019
-
Tennessee receives grant from federal government to address opioid crisis
The Division of TennCare will partner with VUMC as part of the MOM program focusing on 26 rural and urban counties to improve the outcomes for women with opioid use disorder and their infants. Read MoreDec 20, 2019
-
Cell fate signaling
A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy. Read MoreDec 17, 2019
-
Protein dynamics in the beating heart
To study the dynamics of structural proteins in the heart, Vanderbilt investigators generated a cellular tool they expect will be useful for screening drugs that affect heart muscle contraction. Read MoreDec 16, 2019
-
Vanderbilt mechanical engineers earn top materials research awards
Vanderbilt mechanical engineers took home top awards at the Dec. 6 meeting of the Materials Research Society in Boston, Massachusetts. Mechanical engineering professor Kelsey Hatzell received the Materials Research Society Nelson “Buck” Robinson Science and Technology Award for Renewable Energy. Hatzell was selected from more than 25 candidates for her research contributions to renewable energy.... Read MoreDec 13, 2019
-
Gore named to committee on worker health overseas
John Gore, director of the Vanderbilt University Institute of Imaging Science, has been appointed to a National Academies of Sciences, Engineering and Medicine standing committee to advise the Department of State on unexplained health effects on U.S. government employees and their families at overseas embassies. Read MoreDec 12, 2019
-
VUMC-led team isolates antibody that blocks bird flu
VUMC scientists are redoubling their efforts to help people fight off bird flu. Their focus is H7N9, one of the most dangerous of the influenza viruses that have been transmitted from birds to humans. Read MoreDec 12, 2019
-
A new anti-seizure target?
Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy. Read MoreDec 12, 2019
-
Study examines HIV drug’s potential to treat Alzheimer’s
A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease. Read MoreDec 12, 2019
-
New tool may speed antibody, vaccine research
Antibody discovery and vaccine development research may be on the verge of rapidly expanding with data that previously took decades to acquire, thanks to LIBRA-seq, a new tool developed by Vanderbilt University researchers and their colleagues. Read MoreDec 12, 2019